-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Pliant Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q2 2024.
- Pliant Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$60.6M, a 28.1% decline year-over-year.
- Pliant Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$208M, a 30.9% decline year-over-year.
- Pliant Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$184M, a 44.8% decline from 2022.
- Pliant Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$127M, a 30.4% decline from 2021.
- Pliant Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$97.5M, a 134% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)